Equities

InnovAge Holding Corp

INNV:NSQ

InnovAge Holding Corp

Actions
Health CareHealth Care Providers
  • Price (USD)4.71
  • Today's Change0.075 / 1.62%
  • Shares traded17.94k
  • 1 Year change-15.07%
  • Beta0.3185
Data delayed at least 15 minutes, as of Nov 22 2024 17:48 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy0
Outperform0
Hold4
Sell0
Strong Sell0

Share price forecast in USD

The one analyst offering a 12 month price target expects InnovAge Holding Corp share price to rise to 7.00 in the next year from the last price of 4.63.
High51.2%7.00
Med51.2%7.00
Low51.2%7.00

Earnings history & estimates in USD

On Nov 05, 2024, InnovAge Holding Corp reported 1st quarter 2025 losses of -0.04 per share. This result was in line with the consensus of the 4 analysts following the company and exceeded last year's 1st quarter results by 50.00%.
The next earnings announcement is expected on Feb 04, 2025.
Average growth rate-48.96%
InnovAge Holding Corp reported annual 2024 losses of -0.16 per share on Sep 10, 2024.
Average growth rate-122.41%
More ▼

Revenue history & estimates in USD

InnovAge Holding Corp had 1st quarter 2025 revenues of 205.14m. This bettered the 203.33m consensus of the 4 analysts covering the company. This was 12.42% above the prior year's 1st quarter results.
Average growth rate+2.97%
InnovAge Holding Corp had revenues for the full year 2024 of 763.86m. This was 11.01% above the prior year's results.
Average growth rate+6.35%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.